" class="no-js "lang="en-US"> Haemonetics - Medtech Alert
Wednesday, December 06, 2023
Haemonetics | Pharmtech Focus


About Haemonetics


Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Related Story

Haemonetics Appoints James D'Arecca Chief Financial Officer

March 22 2022

Haemonetics Corporation (NYSE: HAE) today announced that James C. D’Arecca will join the Company as Executive […]

Haemonetics Announces VASCADE MVP® Venous Vascular Closure System Gains the First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation Ablation

October 1 2021

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to […]